"HIMG is the region's premier medical group. Providing primary and specialty care, this group includes over 50 physicians and over 200 health care and support personnel."

During the past decade, Huntington Internal Medicine Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Huntington Internal Medicine Group" are "Advanced Breast Cancer" (1 trials), "Basal Cell Carcinoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Huntington Internal Medicine Group" in a lesser frequency.

Most popular intervention types in "Huntington Internal Medicine Group" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "non-interventional" (1 trials). Other intervention names were less common.

The vast majority of trials in "Huntington Internal Medicine Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Huntington Internal Medicine Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Huntington Internal Medicine Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Huntington Internal Medicine Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".